SCHEMBL30746469

SCHEMBL30746469

Cc1c(Cc2ccnc(S(C)(=O)=O)c2F)cncc1Nc1ccc(Br)cc1F

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.34
▸ GAA P10253 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CLK1 P49759 1/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ GRK2 P25098 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ CTDSP1 Q9GZU7 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ TP53 P04637 3/20 0.32
▸ MAPT P10636 1/20 0.32
▸ MAP2K1 Q02750 3/20 0.32
▸ EGFR P00533 1/20 0.32
▸ RET P07949 1/20 0.32
▸ KIF5B P33176 1/20 0.32
▸ KDR P35968 1/20 0.32
▸ MAP2K2 P36507 2/20 0.32
▸ ABCB11 O95342 1/20 0.32
▸ NQO2 P16083 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26984886 1.00 KMT2A (0.34) KMT2AGAAMAPK1CLK1L3MBTL1
SCHEMBL26985498 0.90 PIK3C3 (0.35) KMT2A
SCHEMBL30746363 0.90 PIK3C3 (0.35) KMT2A
SCHEMBL26985349 0.88 NUDT1 (0.42) EGFRKDRNPC1RAB9A
SCHEMBL30746667 0.88 NUDT1 (0.42) EGFRKDRNPC1RAB9A
SCHEMBL30746491 0.88 SLC22A12 (0.36) KMT2AGAAMAPK1CLK1MAP2K1
SCHEMBL26985172 0.88 SLC22A12 (0.36) KMT2AGAAMAPK1CLK1MAP2K1
SCHEMBL30746495 0.87 KMT2A (0.32) KMT2AGAAMAPK1CLK1L3MBTL1
SCHEMBL26985133 0.87 KMT2A (0.32) KMT2AGAAMAPK1CLK1L3MBTL1
SCHEMBL30746420 0.85 RAF1 (0.42) KMT2AGAAMAPK1CLK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120129678-A Mitogen-activated protein kinase (MEK) inhibitors 耐斯泰德医疗公司 2025-06-10 — — CN disclosed
EP-4551558-A2 MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS Nested Therapeutics, Inc. (US) 2025-05-14 — — EP disclosed
WO-2024010925-A2 MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS NESTED THERAPEUTICS, INC. (US) 2024-01-11 — — WO disclosed
Send feedback